Diabetic Macular Edema: What Is Focal and What Is Diffuse?

American Journal of Ophthalmology

Volumn 146, Issue 5, 2008, Pages

  Browning, David J ^a   Altaweel, Michael M ^a   Bressler, Neil M ^a   Bressler, Susan B ^a   Scott, Ingrid U ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL EXAMINATION; DIABETIC MACULAR EDEMA; DISEASE CLASSIFICATION; FLUORESCENCE ANGIOGRAPHY; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RETINA MACULA LUTEA;

EID: 54449089002     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2008.07.013     Document Type: Article

References (86)

1. Krepler K., Wagner J., Sacu S., and Wedrich A. The effect if intravitreal triamcinolone on diabetic macular oedema. Graefes Arch Clin Exp Ophthalmol 243 (2005) 478-481
2. Negi A.K., Vernon S.A., Lim C.S., and Owen-Armstrong K. Intravitreal triamcinolone improves vision in eyes with chronic diabetic macular oedema refractory to laser photocoagulation. Eye 19 (2005) 747-751
3. Tunc M., Onder H.I., and Kaya M. Posterior sub-Tenon's capsule triamcinolone injection combined with focal laser photocoagulation for diabetic macular edema. Ophthalmology 112 (2005) 1086-1091
4. Ciardella A.P., Klancnik J., Schiff W., Barile G., Langton K., and Chang S. Intravitreal triamcinolone for the treatment of refractory diabetic macular edema with hard exudates: an optical coherence tomography study. Br J Ophthalmol 88 (2004) 1131-1136
5. Knudsen L.L. Retrobulbar injection of methylprednisolone in diffuse diabetic macular edema. Retina 24 (2004) 905-909
6. Avci R., and Kaderili B. Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates. Graefes Arch Clin Exp Ophthalmol 244 (2006) 28-35
7. Jonas J.B., Kreissig I., Sofker A., and Degenring R.F. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 121 (2003) 57-61
8. McDonald H.R., and Schatz H. Grid photocoagulation for diffuse macular edema. Retina 5 (1985) 65-72
9. Haritoglou C., Kook D., Neubauer A., et al. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 26 (2006) 999-1005
10. Arevalo J.F., Fromow-Guerra J., Quiroz-Mercado H., et al. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. Ophthalmology 114 (2007) 743-750
11. Bailey C.C., Sparrow J.M., Grey R.H., and Cheng H. The National Diabetic Retinopathy Laser Treatment Audit. I. Maculopathy. Eye 12 (1998) 69-76
12. Kumar A., Sinha S., Azad R., Sharma Y.R., and Vohra R. Comparative evaluation of vitrectomy and dye-enhanced ILM peel with grid laser in diffuse diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 245 (2007) 360-368
13. Abu E., Asrar A.M., and Morse P.H. Laser photocoagulation control of diabetic macular oedema without fluorescein angiography. Br J Ophthalmol 75 (1991) 97-99
14. Aylward G.W. Progressive changes in diabetics and their management. Eye 19 (2005) 1115-1118
15. Zein W.M., Noureddin B.N., Jurdi F.A., Schakal A., and Bashshur Z.F. Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema. Retina 26 (2006) 137-142
16. Bresnick G.H. Diabetic macular edema. A review. Ophthalmology 93 (1986) 989-997
17. Berman D.H., and Friedman E.A. Partial absorption of hard exudates in patients with diabetic end-stage renal disease and severe anemia after treatment with erythropoietin. Retina 14 (1994) 1-5
18. Browning D.J. Diabetic macular edema: a critical review of the early treatment diabetic retinopathy study (ETDRS) series and subsequent studies. Compr Ophthalmol Update 1 (2000) 69-83
19. Greenstein V.C., Chen H., Hood D.C., Holopigian K., Seiple W., and Carr R.E. Retinal function in diabetic macular edema after focal laser photocoagulation. Invest Ophthalmol Vis Sci 41 (2000) 3655-3664
20. Greenstein V.C., Holopigian K., Hood D.C., Seiple W., and Carr R.E. The nature and extent of retinal dysfunction associated with diabetic macular edema. Invest Ophthalmol Vis Sci 41 (2000) 3643-3654
21. Gaucher D., Tadayoni R., Erginay A., Haouchine B., Gaudric A., and Massin P. Optical coherence tomography assessment of the vitreoretinal relationship in diabetic macular edema. Am J Ophthalmol 139 (2005) 807-813
22. Kang S.W., Park C.Y., and Ham D.I. The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema. Am J Ophthalmol 137 (2004) 313-322
23. Early Treatment Diabetic Retinopathy Study Research Group. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effects to fluorescein angiographic and other retinal characteristics at baseline: ETDRS Report No. 19. Arch Ophthalmol 113 (1995) 1144-1155
24. Jonas J.B., Martus P., Degenring R.F., Kreissig I., and Akkoyun I. Predictive factors for visual acuity after intravitreal triamcinolone treatment for diabetic macular edema. Arch Ophthalmol 123 (2005) 1338-1343
25. Cardillo J.A., Melo Jr. L.A., Costa R.A., et al. Comparison of intravitreal versus posterior sub-tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema. Ophthalmology 112 (2005) 1557-1563
26. Blankenship G.W. Diabetic macular edema and argon laser photocoagulation: a prospective randomized study. Ophthalmology 86 (1979) 69-78
27. Talwar D., Sharma N., Pai A., Azad R.V., Kohli A., and Virdi P.S. Contrast sensitivity following focal laser photocoagulation in clinically significant macular oedema due to diabetic retinopathy. Clin and Experiment Ophthalmol 29 (2001) 17-21
28. Lovestam-Adrian M., and Agardh E. Photocoagulation of diabetic macular oedema-complications and visual outcome. Acta Ophthalmol Scand 78 (2000) 667-671
29. Bonini-Filho M.A., Jorge R., Barbosa J.C., Calucci D., Cardillo J.A., and Costa R.A. Intravitreal injection versus sub-Tenon's infusion of triamcinolone acetonide for refractory diabetic macular edema: a randomized clinical trial. Invest Ophthalmol Vis Sci 46 (2005) 3845-3849
30. Schmid K.E., Neumaier-Ammerer B., Stolba U., and Binder S. Effect of grid laser photocoagulation in diffuse diabetic macular edema in correlation to glycosylated haemoglobin (HbA1c). Graefes Arch Clin Exp Ophthalmol 244 (2006) 1446-1452
31. Otani T., and Kishi S. Tomographic findings of foveal hard exudates in diabetic macular edema. Am J Ophthalmol 131 (2001) 50-54
32. Otani T., and Kishi S. Tomographic assessment of vitreous surgery for diabetic macular edema. Am J Ophthalmol 129 (2000) 487-494
33. Thomas D., and Laidlaw D.A. OCT vitreoretinal interface patterns. Eye 17 (2003) 541-542
34. Shahidi M., Ogura Y., Blair N.P., and Zeimer R. Retinal thickness changes after focal laser treatment of diabetic macular oedema. Br J Ophthalmol 78 (1994) 827-830
35. Gibran S.K., Cullinane A., Jungkim S., and Cleary P.E. Intravitreal triamcinolone for diffuse diabetic macular oedema. Eye 20 (2006) 720-724
36. Toda J., Fukushima H., and Kato S. Injection of triamcinolone acetonide into the posterior sub-Tenon capsule for treatment of diabetic macular edema. Retina 27 (2007) 764-769
37. Neubauer A.S., Kook D., Haritoglou C., et al. Bevacizumab and retinal ischemia. Ophthalmology 114 (2007) 2096
38. Ulbig M.W., McHugh D.A., and Hamilton A.M. Diode laser photocoagulation for diabetic macular oedema. Br J Ophthalmol 79 (1995) 318-321
39. Massin P., Duguid G., Erginay A., Haouchine B., and Gaudric A. Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. Am J Ophthalmol 135 (2003) 169-177
40. Watanabe M., Oshima Y., and Emi K. Optical cross-sectional observation of resolved diabetic macular edema associated with vitreomacular separation. Am J Ophthalmol 129 (2000) 264-267
41. Jumper J.M., Embabi S.N., Toth C.A., McCuen II B.W., and Hatchell D.L. Electron immunocytochemical analysis of posterior hyaloid associated with diabetic macular edema. Retina 20 (2000) 63-68
42. Arend O., Remky A., Harris A., Bertram B., Reim M., and Wolf S. Macular microcirculation in cystoid maculopathy of diabetic patients. Br J Ophthalmol 79 (1995) 628-632
43. Chieh J.J., Roth D.B., Liu M., et al. Intravitreal triamcinolone acetonide for diabetic macular edema. Retina 25 (2005) 828-834
44. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report No. 1. Arch Ophthalmol 103 (1985) 1796-1806
45. Wilkinson C.P., Ferris III F.L., Klein R.E., et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110 (2003) 1677-1682
46. Catier A., Tadayoni R., Paques M., et al. Characterization of macular edema from various etiologies by optical coherence tomography. Am J Ophthalmol 140 (2005) 200-206
47. Patz A. Cystoid maculopathy in diabetics. Arch Ophthalmol 94 (1976) 761-768
48. Jensen D.B., and Knudsen L.L. Stereoscopic fluorescein angiography in diabetic maculopathy. Retina 26 (2006) 153-158
49. Jeppesen P., and Bek T. Impaired retinal autoregulation in small retinal arterioles before and after focal laser treatment for diabetic maculopathy. Br J Ophthalmol 90 (2006) 198-201
50. Laursen M.L., Moeller F., Sander B., and Sjoelie A.K. Subthreshold micropulse diode laser treatment in diabetic macular oedema. Br J Ophthalmol 88 (2004) 1173-1179
51. Kinyoun J., Barton F., Fisher M., Hubbard L., Aiello L., and Ferris III F.L. Detection of diabetic macular edema. Ophthalmoscopy versus photography-Early Treatment Diabetic Retinopathy Study Report No. 5. The ETDRS Research Group. Ophthalmology 96 (1989) 746-750 discussion 750-751
52. Sander B., Larsen M., Engler C., et al. Diabetic macular oedema: a comparison of vitreous fluorometry, angiography, and retinopathy. Br J Ophthalmol 86 (2002) 316-320
53. Early Treatment Diabetic Retinopathy Study Research Group. Classification of diabetic retinopathy from fluorescein angiograms. ETDRS Report No. 11. Ophthalmology 98 (1991) 807-822
54. Wallow I.H., and Bindley C.D. Focal photocoagulation of diabetic macular edema. A clinicopathologic case report. Retina 8 (1988) 261-269
55. Yanyali A., Nohutcu A.F., Horozoglu F., and Celik E. Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema. Am J Ophthalmol 139 (2005) 795-801
56. Gandorfer A., Messmer E.M., Ulbig M.W., and Kampik A. Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 20 (2000) 126-133
57. Lee C.M., and Olk R.J. Modified grid laser photocoagulation for diffuse diabetic macular edema. Long-term visual results. Ophthalmology 98 (1991) 1594-1602
58. Akduman L., and Olk R.J. Subthreshold (invisible) modified grid diode laser photocoagulation in diffuse diabetic macular edema (DDME). Ophthalmic Surg Lasers 30 (1999) 706-714
59. Lee C.M., Olk R.J., and Akduman L. Combined modified grid and panretinal photocoagulation for diffuse diabetic macular edema and proliferative diabetic retinopathy. Ophthalmic Surg Lasers 31 (2000) 292-300
60. Akduman L., and Olk R.J. Laser photocoagulation of diabetic macular edema. Ophthalmic Surg Lasers 28 (1997) 387-408
61. Yanyali A., Horozoglu F., Celik E., and Nohutcu A.F. Long-term outcomes of pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema. Retina 27 (2007) 557-566
62. Martidis A., Duker J.S., Greenberg P.B., et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109 (2002) 920-927
63. Diabetic Retinopathy Clinical Research Network, Scott I.U., Edwards A.R., et al. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology 114 (2007) 1860-1867
64. Kylstra J.A., Brown J.C., Jaffe G.J., et al. The importance of fluorescein angiography in planning laser treatment of diabetic macular edema. Ophthalmology 106 (1999) 2068-2073
65. Browning D.J., and Fraser C.M. Regional patterns of sight-threatening diabetic macular edema. Am J Ophthalmol 140 (2005) 117-124
66. Sadda S.R., Tan O., Walsh A.C., Schuman J.S., Varma R., and Huang D. Automated detection of clinically significant macular edema by grid scanning optical coherence tomography. Ophthalmology 113 (2006) 1187 el-e12
67. Kim B.Y., Smith S.D., and Kaiser P.K. Optical coherence tomographic patterns of diabetic macular edema. Am J Ophthalmol 142 (2006) 405-412
68. Brasil O.F., Smith S.D., Galor A., Lowder C.Y., Sears J.E., and Kaiser P.K. Predictive factors of short-term visual outcome after intravitreal triamcinolone acetonide injection for diabetic macular oedema: an optical coherence tomography study. Br J Ophthalmol 91 (2007) 761-765
69. Browning D.J., McOwen M.D., Bowen Jr. R.M., and O'Marah T.L. Comparison of the clinical diagnosis of diabetic macular edema with diagnosis by optical coherence tomography. Ophthalmology 111 (2004) 712-715
70. Audren F., LeCleire-Collet A., Erginay A., et al. Intravitreal triamcinolone acetonide for diffuse diabetic macular edema: phase 2 trial comparing 4 mg vs 2 mg. Am J Ophthalmol 142 (2006) 794-799
71. Shulman S., Ferencz J.R., Gilady G., Ton Y., and Assia E. Prognostic factors for visual acuity improvement after intravitreal triamcinolone injection. Eye 21 (2007) 1067-1070
72. Carpineto P., Ciancaglini M., Di Antonio L., Gavalas C., and Mastropasqua L. Fundus microperimetry patterns of fixation in type 2 diabetic patients with diffuse macular edema. Retina 27 (2007) 21-29
73. Shimura M., Yasuda K., Nakazawa T., Ota S., and Tamai M. Effective treatment of diffuse diabetic macular edema by temporal grid pattern photocoagulation. Ophthalmic Surg Lasers Imaging 35 (2004) 270-280
74. Kang S.W., Sa H.S., Cho H.Y., and Kim J.I. Macular grid photocoagulation after intravitreal triamcinolone acetonide for diffuse diabetic macular edema. Arch Ophthalmol 124 (2006) 653-658
75. Massin P., Audren F., Haouchine B., et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 111 (2004) 218-224
76. Audren F., Tod M., Massin P., et al. Pharmacokinetic-pharmacodynamic modeling of the effect of triamcinolone ecetonide on central macular thickness in patients with diabetic macular edema. Invest Ophthalmol Vis Sci 45 (2004) 3435-3441
77. Lobo C.L., Bernardes R.C., de Abreu J.R., and Cunha-Vaz J.G. One-year follow-up of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild nonproliferative retinopathy. Arch Ophthalmol 119 (2001) 1469-1474
78. Lobo C.L., Bernardes R.C., and Cunha-Vaz J.G. Alternations of the blood-retinal barrier and retinal thickness in preclinical retinopathy in subjects with type 2 diabetes. Arch Ophthalmol 118 (2000) 1364-1369
79. Bailey C.C., Sparrow J.M., Grey R.H., and Cheng H. The National Diabetic Retinopathy Laser Treatment Audit. III. Clinical outcomes. Eye 13 (1999) 151-159
80. Khairallah M., Zeghidi H., Ladjimi A., et al. Primary intravitreal triamcinolone ecetonide for diabetic massive macular hard exudates. Retina 25 (2005) 835-839
81. Spandau U.H., Derse M., Schmitz-Valckenberg P., Papoulis C., and Jonas J.B. Dosage dependency of intraviteal triamcinolone ecetonide as treatment for diabetic macular oedema. Br J Ophthalmol 89 (2005) 999-1003
82. Diabetic Retinopathy Clinical Research Network. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology 114 (2007) 525-536
83. Bresnick G.H. Diabetic maculopathy. A critical review highlighting diffuse macular edema. Ophthalmology 90 (1983) 1301-1317
84. Luttrull J.K., Musch D.C., and Mainster M.A. Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular oedema. Br J Ophthalmol 89 (2005) 74-80
85. Shimura M., Nakazawa T., Yasuda K., Shiono T., and Nishida K. Pretreatment of posterior sub-Tenon injection of triamcinolone acetonide has beneficial effects for grid pattern photocoagulation against diffuse diabetic macular oedema. Br J Ophthalmol 91 (2007) 449-454
86. Funatsu H., Yamashita H., Ikeda T., Mimura T., Shimizu E., and Hori S. Relation of diabetic macular edema to cytokines and posterior vitreous detachment. Am J Ophthalmol 135 (2003) 321-327